Rezultati - X. Cynthia

Refine Results
  1. 1
    Letrozole in the neoadjuvant setting: the P024 trial

    Letrozole in the neoadjuvant setting: the P024 trial od Matthew J. Ellis, X. Cynthia

    Izdano 2007
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

    Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy od Parvin F. Peddi, Matthew J. Ellis, X. Cynthia

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics

    Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics od X. Cynthia, James W. Janetka, Helen Piwnica‐Worms

    Izdano 2010
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer

    Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer od Sandeep Rajput, Nimmish Khera, Zhanfang Guo, Jeremy Hoog, Shunqiang Li, X. Cynthia

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians

    Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians od Foluso O. Ademuyiwa, Tao Yu, Jingqin Luo, Katherine N. Weilbaecher, X. Cynthia

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in <scp>US</scp> women 18 to 64 years old

    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in <scp>US</scp> women 18 to 64 years old od Christine D. Hsu, Xiaoyan Wang, David V. Habif, X. Cynthia, Kimberly Johnson

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    <i>HER2</i>-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor

    <i>HER2</i>-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor od Noa Ben-Baruch, Ron Bose, Shyam M. Kavuri, X. Cynthia, Matthew J. Ellis

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models

    Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models od Siguang Xu, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, X. Cynthia

    Izdano 2013
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1.

    Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. od Dror I. Baruch, J A Gormely, X. Cynthia, R J Howard, B L Pasloske

    Izdano 1996
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy od Farrokh Dehdashti, Ningying Wu, X. Cynthia, Michael Naughton, John A. Katzenellenbogen, Barry A. Siegel

    Izdano 2021
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Protein Subcellular Localization Profiling of Breast Cancer Cells by Dissociable Antibody MicroArray (DAMA) Staining

    Protein Subcellular Localization Profiling of Breast Cancer Cells by Dissociable Antibody MicroArray (DAMA) Staining od Fu, Guanyuan, Song, X. Cynthia, Yang, Xufen, Peng, Tao, Wang, Yingjian, Zhou, G. Wayne

    Izdano 2010
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice

    Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice od Schackman, Bruce R, Haas, David W, Park, Sanghee S, Li, X Cynthia, Freedberg, Kenneth A

    Izdano 2015
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    US breast cancer mortality trends in young women according to race

    US breast cancer mortality trends in young women according to race od Foluso O. Ademuyiwa, Feng Gao, Hao Lin, Daniel Morgensztern, Rebecca Aft, X. Cynthia, Matthew J. Ellis

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer

    Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer od Beomyoung Cho, Yunan Han, Min Lian, Graham A. Colditz, Jason D. Weber, X. Cynthia, Ying Liu

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

    Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Resp... od Carla S. Fisher, X. Cynthia, William E. Gillanders, Rebecca Aft, Timothy J. Eberlein, Feng Gao, Julie A. Margenthaler

    Izdano 2011
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

    Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer od César Sánchez, X. Cynthia, Robert J. Crowder, Therese Guintoli, Chanpheng Phommaly, Feng Gao, Lin Li, Matthew J. Ellis

    Izdano 2011
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells

    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells od Venkataswarup Tiriveedhi, Timothy P. Fleming, Peter S. Goedegebuure, Michael Naughton, X. Cynthia, Craig Lockhart, Feng Gao, William E. Gillanders, T. Mohanakumar

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs

    Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs od Tahir Rahman, John M. Sahrmann, Margaret A. Olsen, Katelin B. Nickel, J. Philip Miller, X. Cynthia, Richard A. Grucza

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma

    Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma od X. Cynthia, Martha Q. Lacy, John F. Rompala, Angela Dispenzieri, S. Vincent Rajkumar, Philip R. Greipp, Rafaël Fonseca, Robert A. Kyle, Morie A. Gertz

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance)

    Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase... od Harold J. Burstein, Constance Cirrincione, William T. Barry, Helen K. Chew, Sara M. Tolaney, Diana Lake, X. Cynthia, Kimberly Blackwell, Eric P. Winer, Clifford A. Hudis

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: